| Analysis | Metabolite Name | Measured Value | Units | Genotype | TREATMENT | TIME_POINT |
|---|---|---|---|---|---|---|
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.055253229 | Normalized AUC | WT | LPS | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.183582432 | Normalized AUC | WT | LPS | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.243528606 | Normalized AUC | WT | LPS | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.328900868 | Normalized AUC | WT | LPS | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.437602701 | Normalized AUC | WT | anti-CD40 | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.447111872 | Normalized AUC | WT | anti-CD40 | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.453627305 | Normalized AUC | SCAP KO | anti-CD40 | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.463435714 | Normalized AUC | WT | anti-CD40 | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.491757266 | Normalized AUC | WT | anti-CD40 | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.519633608 | Normalized AUC | SCAP KO | LPS | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.530675411 | Normalized AUC | SCAP KO | anti-CD40 | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.533769428 | Normalized AUC | WT | LPS | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.558776955 | Normalized AUC | SCAP KO | anti-CD40 | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.59204803 | Normalized AUC | WT | LPS | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.608665551 | Normalized AUC | WT | LPS | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.613243627 | Normalized AUC | SCAP KO | LPS | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.62502451 | Normalized AUC | SCAP KO | anti-CD40 | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.707373724 | Normalized AUC | SCAP KO | LPS | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.719608693 | Normalized AUC | SCAP KO | LPS | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.729838914 | Normalized AUC | SCAP KO | LPS | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.746952967 | Normalized AUC | WT | LPS | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.775809162 | Normalized AUC | SCAP KO | LPS | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.906861346 | Normalized AUC | WT | anti-CD40 | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.912074956 | Normalized AUC | WT | anti-CD40 | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.963053555 | Normalized AUC | WT | anti-CD40 | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 1.036946445 | Normalized AUC | SCAP KO | anti-CD40 | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 1.09848948 | Normalized AUC | SCAP KO | LPS | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 1.17190037 | Normalized AUC | SCAP KO | LPS | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 1.24472807 | Normalized AUC | SCAP KO | anti-CD40 | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 1.28941482 | Normalized AUC | SCAP KO | anti-CD40 | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 1.434321677 | Normalized AUC | WT | anti-CD40 | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 1.747968737 | Normalized AUC | SCAP KO | anti-CD40 | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 2.352935616 | Normalized AUC | WT | Freshly isolated (No treatment) | 0hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 2.508822539 | Normalized AUC | WT | Freshly isolated (No treatment) | 0hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 2.730602332 | Normalized AUC | SCAP KO | Freshly isolated (No treatment) | 0hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 3.096819756 | Normalized AUC | SCAP KO | Freshly isolated (No treatment) | 0hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 3.17839262 | Normalized AUC | SCAP KO | Freshly isolated (No treatment) | 0hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 3.964001876 | Normalized AUC | SCAP KO | Freshly isolated (No treatment) | 0hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 4.086668479 | Normalized AUC | WT | Freshly isolated (No treatment) | 0hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 5.003229207 | Normalized AUC | WT | Freshly isolated (No treatment) | 0hr |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|